CDHR5 inhibits proliferation of hepatocellular carcinoma and predicts clinical prognosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CDHR5 inhibits proliferation of hepatocellular carcinoma and predicts clinical prognosis
Authors
Keywords
Biomarker, CDHR5, Hepatocellular carcinoma, Prognosis, Proliferation
Journal
IRISH JOURNAL OF MEDICAL SCIENCE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-03
DOI
10.1007/s11845-019-02092-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression
- (2018) Qun Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Clinical Significance of Ubiquitin Specific Protease 7 (USP7) in Predicting Prognosis of Hepatocellular Carcinoma and its Functional Mechanisms
- (2018) Xujing Wang et al. MEDICAL SCIENCE MONITOR
- Targeting mTORC1/2 Complexes Inhibit Tumorigenesis and Enhance Sensitivity to 5-Flourouracil (5-FU) in Hepatocellular Carcinoma: A Preclinical Study of mTORC1/2-Targeted Therapy in Hepatocellular Carcinoma (HCC)
- (2018) Yu Zhang et al. MEDICAL SCIENCE MONITOR
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling
- (2018) Yun-Fei Xu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Significance of PYK2 level as a prognosis predictor in patients with colon adenocarcinoma after surgical resection
- (2018) Shufang Liu et al. OncoTargets and Therapy
- TBL1XR1 predicts isolated tumor cells and micrometastasis in patients with TNM stage I/II colorectal cancer
- (2017) Hongda Liu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Prognostic significance of TBL1XR1 in predicting liver metastasis for early stage colorectal cancer
- (2017) Hongda Liu et al. SURGICAL ONCOLOGY-OXFORD
- Correlations between TBL1XR1 and recurrence of colorectal cancer
- (2017) Hongda Liu et al. Scientific Reports
- Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes
- (2016) L Montorsi et al. Cell Death & Disease
- Epigenetic silencing of the MUPCDH gene as a possible prognostic biomarker for cyst growth in ADPKD
- (2015) Yu Mi Woo et al. Scientific Reports
- Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer
- (2012) Xian Zhong et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Downregulation of PCDH9 predicts prognosis for patients with glioma
- (2012) Chunlin Wang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Role of PCDH10 and its hypermethylation in human gastric cancer
- (2011) Zesong Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Down-regulation of μ-protocadherin expression is a common event in colorectal carcinogenesis
- (2011) Lorena Losi et al. HUMAN PATHOLOGY
- PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer
- (2008) J S Yu et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now